Discover the full record of transactions filed by Olson Kenneth Fletcher, Chief Operating Officer. Insider active across 2 companies, notably HARVARD BIOSCIENCE INC. In total, 6 reports have been recorded. The latest transaction was disclosed on 29 December 2021 — Retenue fiscale. Regulator: SEC (Form 4). All data is accessible without signup.
Kenneth Fletcher Olson is the Chief Operating Officer at Harvard Bioscience Inc. He oversees the company's operations, playing a key role in operational efficiency and strategy implementation.